The delta opioid receptor: a novel therapeutic target for pain and even more ...

被引：0
|
作者：
Gaveriaux-Ruff, C. [1 ]
机构：
[1] Univ Strasbourg, Dept Neurobiol & Genet, INSERM, IGBMC,CNRS,UMR7104,U964, F-67400 Illkirch Graffenstaden, France
来源：
DOULEUR ET ANALGESIE | 2009年 / 22卷 / 04期
关键词：
Opioid receptor; Delta; Chronic pain; Anxiety depression; ANTIDEPRESSANT-LIKE ACTIVITIES; PROTEIN-COUPLED RECEPTORS; RAT MODEL; AGONIST SNC80; NEUROPATHIC PAIN; FUNCTIONAL COMPETENCE; ANTINOCICEPTIVE PROPERTIES; CHRONIC INFLAMMATION; MORPHINE-TOLERANCE; RHESUS-MONKEYS;
D O I：
10.1007/s11724-009-0146-3
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The delta opioid receptor is a novel target for pain treatment. The delta receptor appears different from the mu receptor as it is poorly effective for acute nociception but becomes more active in pathological situations. The interest for this receptor has increased recently with the identification of novel ligands and the study of its intracellular traffic. In addition, delta receptor activation lowers anxiety and depression. This review presents the recent knowledge on delta opioid analgesia and on the other neurobiological effects of delta receptor activation.
引用
收藏
页码：201 / 209
页数：9
相关论文
共 50 条
  • [1] DELTA OPIOID RECEPTOR SIGNALING IN ENDOSOMES: A NOVEL THERAPEUTIC TARGET FOR TREATING VISCERAL PAIN
    Jimenez-Vargas, Nestor N.
    Yu, Yang
    Reed, David E.
    Lomax, Alan E.
    Schmidt, Brian
    Vanner, Stephen
    Bunnett, Nigel W.
    GASTROENTEROLOGY, 2020, 158 (06) : S1032 - S1032
  • [2] The Delta Opioid Receptor as a Novel Therapeutic Target for Headache Disorders
    Pradhan, Amynah
    Tipton, Alycia
    Moye, Laura
    Novack, Madeline
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S214 - S214
  • [3] Novel therapeutic target for visceral pain: Opioid receptor signaling by endosomes
    Vargas, Nestor N. Jimenez
    Yu, Yang
    Schmidt, Brian L.
    Bunnett, Niguel W.
    Vanner, Stephen
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32
  • [4] The Delta-Opioid Receptor; a Target for the Treatment of Pain
    Quirion, Beatrice
    Bergeron, Francis
    Blais, Veronique
    Gendron, Louis
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [5] Pain Perception and the Opioid Receptor Delta 1
    Hilgemeier, Adam T.
    Serna, David M.
    Patel, Tarak P.
    Rambaran, Kerry Anne
    Amin, Zubair M.
    An, Jie
    Alzghari, Saeed K.
    CUREUS, 2018, 10 (02):
  • [6] Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain
    Jimenez-Vargas, Nestor N.
    Gong, Jing
    Wisdom, Matthew J.
    Jensen, Dane D.
    Latorre, Rocco
    Hegron, Alan
    Teng, Shavonne
    DiCello, Jesse J.
    Rajasekhar, Pradeep
    Veldhuis, Nicholas A.
    Carbone, Simona E.
    Yu, Yang
    Lopez-Lopez, Cintya
    Jaramillo-Polanco, Josue
    Canals, Meritxell
    Reed, David E.
    Lomax, Alan E.
    Schmidt, Brian L.
    Leong, Kam W.
    Vanner, Stephen J.
    Halls, Michelle L.
    Bunnett, Nigel W.
    Poole, Daniel P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (26) : 15281 - 15292
  • [7] Peptidomimetics Exhibiting Mu Opioid Receptor (MOPr) Agonist/Delta Opioid Receptor (DOPr) Antagonist Activity as Novel Pain Therapeutics
    Griggs, Nicholas
    Bender, Aaron
    Gao, Chao
    Anand, Jessica
    Traynor, John
    Mosberg, Henry
    FASEB JOURNAL, 2016, 30
  • [8] The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target
    Moye, Laura S.
    Novack, Madeline L.
    Tipton, Alycia F.
    Krishnan, Harish
    Pandey, Subhash C.
    Pradhan, Amynah A. A.
    CEPHALALGIA, 2019, 39 (01) : 77 - 90
  • [9] δ-Opioid receptor as a potential therapeutic target for ischemic stroke
    Kalpana Subedi
    Hongmin Wang
    NeuralRegenerationResearch, 2020, 15 (01) : 20 - 24
  • [10] δ-Opioid receptor as a potential therapeutic target for ischemic stroke
    Subedi, Kalpana
    Wang, Hongmin
    NEURAL REGENERATION RESEARCH, 2020, 15 (01) : 20 - 24
12345